JMI Syringes & Medical Devices (DHA:JMISMDL) ROCE %: 2.08% (As of Mar. 2025)


DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT135.90
View Full Analysis

What is JMI Syringes & Medical Devices ROCE %?

JMI Syringes & Medical Devices DHA:JMISMDL -2.44% 75 ROCE % is 2.08% as of Mar. 2025. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. JMI Syringes & Medical Devices's annualized ROCE % for the quarter that ended in Mar. 2025 was 2.08%.

JMI Syringes & Medical Devices  (DHA:JMISMDL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

JMI Syringes & Medical Devices ROCE % Related Terms

JMI Syringes & Medical Devices ROCE % Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices ROCE % Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.06 7.02 7.81 2.79 4.95

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.61 9.94 5.92 7.59 2.08
DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices ROCE % Calculation

JMI Syringes & Medical Devices's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=133.591/( ( (2998.679 - 302.143) + (2957.068 - 250.73) )/ 2 )
=133.591/( (2696.536+2706.338)/ 2 )
=133.591/2701.437
=4.95 %

JMI Syringes & Medical Devices's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=56.56/( ( (3007.317 - 280.674) + (3058.033 - 333.162) )/ 2 )
=56.56/( ( 2726.643 + 2724.871 )/ 2 )
=56.56/2725.757
=2.08 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.08% mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a ROCE % of 2.08% as of Mar. 2025.
Is JMI Syringes & Medical Devices' ROCE % too high?
JMI Syringes & Medical Devices' current ROCE % is 2.08%. The Medical Devices & Instruments industry median ROCE % is 2.20. JMI Syringes & Medical Devices' value of 2.08% is 5.5% below this industry median. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' ROCE % compare to ISRG and BDX?
JMI Syringes & Medical Devices' ROCE % of 2.08% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. JMI Syringes & Medical Devices' value of 2.08% is 5.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Syringes & Medical Devices's current ROCE % of 2.08% is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Syringes & Medical Devices's current ROCE % is 2.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current ROCE % of 2.08%. The current ROCE % is 2.08% and 5.5% below the Medical Devices & Instruments industry median of 2.20. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current ROCE % is 2.08% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT135.90
Price